Skip to main content
GeneralHomeInvestorsNewsUzedy

Teva and MedinCell Announce Positive Results for Registration Trial of Investigational Extended-Release Subcutaneous Injectable Risperidone for Patients with Schizophrenia

By January 7, 2021March 15th, 2024No Comments1 min read